ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2,5,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,7,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
3,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
